Jeff Stanwix

Jeff Stanwix is a Senior Research Associate at Mitobridge, Inc., where since September 2015, involvement has focused on cell-based and biochemical assays to assess the impact of lead compounds on mitochondrial function in kidney injury models. Prior experience includes a Co-Op Internship at Pfizer in the Rare Disease Research Unit, contributing to molecular signaling and protein analysis for Duchenne's Muscular Dystrophy projects. Additional internship roles at Genzyme Sanofi and Woods Hole Oceanographic Institution provided experience in therapeutic antibody development and environmental research, respectively. Jeff Stanwix earned a Bachelor's degree in Biology from Northeastern University in 2015.